Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differentiation induction in myeloid leukemic cells.

U Gullberg, K Peetre, I Olsson

    Medical Oncology and Tumor Pharmacotherapy
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of dry period length on milk production and energy balance in two cow breeds.

    Animal : an international journal of animal bioscience·2017
    Same author

    The DEK oncoprotein and its emerging roles in gene regulation.

    Leukemia·2015
    Same author

    Genetic relationships between growth characters in Salix viminalis grown in Sweden.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
    Same author

    Components of resistance of leaf rust (Melamspora laricii epitea Kleb./Melampsora ribesii-viminalis Kleb.) in Salix viminalis L.

    TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
    Same author

    Effects of experimental manipulations of salinity and maturation status on the physiological condition and mortality of homing adult sockeye salmon held in a laboratory.

    Physiological and biochemical zoology : PBZ·2010
    Same author

    Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.

    Leukemia·2010
    Same journal

    Treatment of ovarian cancer: the state of the art.

    Medical oncology and tumor pharmacotherapy·1993
    Same journal

    Clinical evaluation of the CORDIS vascular access port systems: a multicenter study.

    Medical oncology and tumor pharmacotherapy·1993
    Same journal

    Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: I. Application of the HEV-binding assay to a clinical series.

    Medical oncology and tumor pharmacotherapy·1993
    Same journal

    Ultrastructural investigation of DNA in megakaryoblastic leukemia by using osmium-ammine-B: comparison with several types of leukemia.

    Medical oncology and tumor pharmacotherapy·1993
    Same journal

    T-lymphocyte sub-populations in orbito-ocular granulocytic sarcoma (OOGS) and acute myelocytic leukemia (AML): a preliminary study.

    Medical oncology and tumor pharmacotherapy·1993
    Same journal

    Low dose cyclophosphamide, alpha-interferon and continuous infusions of interleukin-2 in advanced renal cell carcinoma.

    Medical oncology and tumor pharmacotherapy·1993
    See all related articles

    Leukemia cell maturation arrest is reversible. Inducing differentiation in leukemia cells, using agents like differentiation-inducing factor (DIF), can inhibit proliferation and may offer clinical utility.

    Area of Science:

    • Hematology
    • Cell Biology
    • Molecular Biology

    Background:

    • Leukemia is characterized by a maturation arrest, preventing cancer cells from differentiating.
    • Immortalized leukemic cell lines suggest this arrest can be reversed.
    • Restoring the link between proliferation and differentiation is a key therapeutic goal.

    Purpose of the Study:

    • To investigate methods for inducing differentiation in leukemic cells.
    • To explore the role of differentiation-inducing factor (DIF) in leukemia cell maturation.
    • To assess the potential clinical utility of differentiation induction agents.

    Main Methods:

    • Utilized immortalized human leukemic cell lines (HL-60, U-937).
    • Applied various differentiation-inducing agents, including phorbol diesters, retinoic acid, and 1,25-dihydroxycholecalciferol.

    Related Experiment Videos

  • Investigated the effects of differentiation-inducing factor (DIF) from lymphocytes on cell lines and primary leukemia cells.

    • Main Results:

    • HL-60 and U-937 cell lines successfully differentiated upon incubation with various agents.
    • DIF induced maturation of HL-60 cells into macrophage-like cells, inhibiting proliferation.
    • DIF demonstrated growth inhibitory effects on leukemic subclones, fresh acute myeloid leukemia cells, and normal progenitors.

    Conclusions:

    • Multiple pathways exist for inducing differentiation in leukemia.
    • Differentiation-inducing factor (DIF) shows promise for inhibiting leukemia cell growth.
    • Synergistic effects between agents suggest potential clinical applications for leukemia treatment.